loadpatents
name:-0.041453838348389
name:-0.028045892715454
name:-0.013939142227173
QIAN; Wenyuan Patent Filings

QIAN; Wenyuan

Patent Applications and Registrations

Patent applications and USPTO patent grants for QIAN; Wenyuan.The latest application filed is for "crystalline form of atr inhibitor and use thereof".

Company Profile
14.33.46
  • QIAN; Wenyuan - Shanghai CN
  • QIAN; Wenyuan - Nanjing Jiangsu Province
  • Qian; Wenyuan - Thousand Oaks CA
  • Qian; Wenyuan - Newbury Park CA
  • Qian; Wenyuan - Camarillo CA
  • Qian; Wenyuan - Carmarillo CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Crystalline Form Of Atr Inhibitor And Use Thereof
App 20220281858 - WANG; Jian ;   et al.
2022-09-08
ATR inhibitor and application thereof
Grant 11,434,232 - Qian , et al. September 6, 2
2022-09-06
Benzimidazole derivatives and use thereof as IDH1 inhibitors
Grant 11,407,717 - Wang , et al. August 9, 2
2022-08-09
Pyrrolopyrimidine Compound And Use Thereof
App 20220227788 - QIAN; Wenyuan ;   et al.
2022-07-21
Crystal Form Of Wee1 Inhibitor Compound And Use Thereof
App 20220220120 - QIAN; Wenyuan ;   et al.
2022-07-14
Heterocyclic compound as CSF-1R inhibitor and use thereof
Grant 11,384,065 - Qian , et al. July 12, 2
2022-07-12
Polymorph of HDAC6-selective inhibitor and application thereof
Grant 11,345,682 - Guo , et al. May 31, 2
2022-05-31
Prostacyclin receptor agonist
Grant 11,299,475 - Qian , et al. April 12, 2
2022-04-12
Quinolino-pyrrolidin-2-one derivative and application thereof
Grant 11,230,549 - Qian , et al. January 25, 2
2022-01-25
Substituted 1,3,4-thiadiazoles as GLS1 inhibitors
Grant 11,230,544 - Liao , et al. January 25, 2
2022-01-25
Salt Of Syk Inhibitor And Crystalline Form Thereof
App 20220017498 - QIAN; Wenyuan ;   et al.
2022-01-20
Pyrimidopyrazolone Derivative As Wee1 Inhibitor And Use Thereof
App 20210403451 - QIAN; Wenyuan ;   et al.
2021-12-30
Quinolino-pyrrolidin-2-one Derivative And Application Thereof
App 20210380599 - QIAN; Wenyuan ;   et al.
2021-12-09
Medical Use Of Prostacyclin Receptor Agonist
App 20210338665 - HE; Kunlun ;   et al.
2021-11-04
Benzimidazole Derivatives And Use Thereof As Idh1 Inhibitors
App 20210206728 - WANG; Dahai ;   et al.
2021-07-08
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
Grant 11,021,493 - Allen , et al. June 1, 2
2021-06-01
[1,2,4]triazolo[1,5-a]pyridine Compound As Jak Inhibitor And Use Thereof
App 20210155621 - MAO; Weiwei ;   et al.
2021-05-27
Polymorph Of Hdac6-selective Inhibitor And Application Thereof
App 20210147394 - GUO; Qiang ;   et al.
2021-05-20
Heterocyclic Compound As Csf-1r Inhibitor And Use Thereof
App 20210107894 - QIAN; Wenyuan ;   et al.
2021-04-15
Prostacyclin Receptor Agonist
App 20210087168 - QIAN; Wenyuan ;   et al.
2021-03-25
1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one derivative as Wee1 inhibitor
Grant 10,954,253 - Qian , et al. March 23, 2
2021-03-23
Atr Inhibitor And Application Thereof
App 20200399260 - QIAN; Wenyuan ;   et al.
2020-12-24
Macrocyclic Compound Serving As Wee1 Inhibitor And Applications Thereof
App 20200325145 - QIAN; Wenyuan ;   et al.
2020-10-15
1,4-thiazine Dioxide And 1,2,4-thiadiazine Dioxide Derivatives As Beta-secretase Inhibitors And Methods Of Use
App 20200231601 - ALLEN; Jennifer R. ;   et al.
2020-07-23
1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one Derivative As Wee1 Inhibitor
App 20200017528 - QIAN; Wenyuan ;   et al.
2020-01-16
Benzimidazole-linked indole compound acting as novel divalent IAP antagonist
Grant 10,508,103 - Sun , et al. Dec
2019-12-17
Benzimidazole-linked Indole Compound Acting As Novel Divalent Iap Antagonist
App 20190135794 - SUN; Fei ;   et al.
2019-05-09
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
Grant 10,246,429 - Allen , et al.
2019-04-02
Vinyl Fluoride Cyclopropyl Fused Thiazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20180222876 - ALLEN; Jennifer R. ;   et al.
2018-08-09
Cyclopropyl Fused Thiazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20170267673 - ALLEN; Jennifer R. ;   et al.
2017-09-21
Glycine transporter-1 inhibitors
Grant 9,663,476 - Hitchcock , et al. May 30, 2
2017-05-30
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
Grant 9,611,261 - Minatti , et al. April 4, 2
2017-04-04
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
Grant 9,550,762 - Allen , et al. January 24, 2
2017-01-24
Azetidine and piperidine compounds useful as PDE10 inhibitors
Grant 9,493,459 - Allen , et al. November 15, 2
2016-11-15
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20160280695 - MINATTI; Ana Elena ;   et al.
2016-09-29
Azetidine And Piperidine Compounds Useful As Pde10 Inhibitors
App 20160176874 - ALLEN; Jennifer R. ;   et al.
2016-06-23
Azetidine and piperidine compounds useful as PDE10 inhibitors
Grant 9,303,028 - Allen , et al. April 5, 2
2016-04-05
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
Grant 9,296,734 - Minatti , et al. March 29, 2
2016-03-29
Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhibitors and Methods of Use
App 20160046618 - ALLEN; Jennifer R. ;   et al.
2016-02-18
Heterobicyclic compounds
Grant 9,174,992 - Allen , et al. November 3, 2
2015-11-03
Glycine Transporter-1 Inhibitors
App 20150307457 - Hitchcock; Stephen A. ;   et al.
2015-10-29
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20150252011 - Minatti; Ana Elena ;   et al.
2015-09-10
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
Grant 9,085,576 - Minatti , et al. July 21, 2
2015-07-21
Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
Grant 8,883,782 - Cheng , et al. November 11, 2
2014-11-11
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20140275058 - MINATTI; Ana Elena ;   et al.
2014-09-18
Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20140249104 - MINATTI; Ana Elena ;   et al.
2014-09-04
Azetidine And Piperidine Compounds Useful As Pde10 Inhibitors
App 20140148435 - Allen; Jennifer R. ;   et al.
2014-05-29
Glycine transporter-1 inhibitors
Grant 8,735,383 - Stephen , et al. May 27, 2
2014-05-27
Azetidine and piperidine compounds useful as PDE10 inhibitors
Grant 8,691,986 - Allen , et al. April 8, 2
2014-04-08
Amino-oxazines And Amino-dihydrothiazine Compounds As Beta-secretase Modulators And Methods Of Use
App 20140045828 - CHEN; Jian ;   et al.
2014-02-13
Azetidine And Piperidine Compounds Useful As Pde10 Inhibitors
App 20130338138 - Allen; Jennifer R. ;   et al.
2013-12-19
Heterobicyclic Compounds
App 20130225552 - Allen; Jennifer R. ;   et al.
2013-08-29
Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use
Grant 8,426,447 - White , et al. April 23, 2
2013-04-23
Glycine transporter-1 inhibitors
Grant 8,258,306 - Hitchcock , et al. September 4, 2
2012-09-04
Glycine Transporter-1 Inhibitors
App 20120195985 - Hitchcock; Stephen ;   et al.
2012-08-02
Glycine transporter-1 inhibitors
Grant 8,183,244 - Hitchcock , et al. May 22, 2
2012-05-22
Amino-Oxazines and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use
App 20110251186 - CHEN; Jian J. ;   et al.
2011-10-13
Spiro-tetracyclic Ring Compounds As Beta-secretase Modulators And Methods Of Use
App 20110251190 - CHENG; Yuan ;   et al.
2011-10-13
Glycine Transporter-1 Inhibitors
App 20100298341 - Hitchcock; Stephen A. ;   et al.
2010-11-25
Spiro-tricyclic Ring Compounds As Beta-secretase Modulators And Methods Of Use
App 20100087429 - White; Ryan ;   et al.
2010-04-08
1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use
Grant 7,662,811 - Askew, Jr. , et al. February 16, 2
2010-02-16
Triazoles and methods of use
Grant 7,612,060 - Aya , et al. November 3, 2
2009-11-03
Bradykinin 1 Receptor Antagonists
App 20090227601 - Zhu; Jiawang ;   et al.
2009-09-10
Glycine Transporter-1 Inhibitors
App 20090227595 - Hitchcock; Stephen ;   et al.
2009-09-10
Glycine transporter-1 inhibitors
Grant 7,538,114 - Hitchcock , et al. May 26, 2
2009-05-26
Piperazine derivatives and methods of use
App 20090054460 - Chen; Jian J. ;   et al.
2009-02-26
Compounds And Methods Of Use
App 20090048224 - Groneberg; Robert D. ;   et al.
2009-02-19
Compounds and methods of use
Grant 7,425,631 - Groneberg , et al. September 16, 2
2008-09-16
Piperazine derivatives and methods of use
Grant 7,393,852 - Chen , et al. July 1, 2
2008-07-01
Glycine transporter-1 inhibitors
App 20080004289 - Hitchcock; Stephen ;   et al.
2008-01-03
Substituted sulfones and methods of use
App 20060111347 - Askew; Benny C. JR. ;   et al.
2006-05-25
Triazoles and methods of use
App 20060100213 - Aya; Toshihiro ;   et al.
2006-05-11
1,2,3,4-Tetrahydropyrazin-2-yl acetamides and methods of use
App 20060025400 - Askew; Benny C. JR. ;   et al.
2006-02-02
Compounds and methods of use
App 20050124654 - Groneberg, Robert D. ;   et al.
2005-06-09
Piperazine derivatives and methods of use
App 20050014749 - Chen, Jian J. ;   et al.
2005-01-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed